pHLsec-FAP
(Plasmid
#239817)
-
PurposeExpresses human fibroblast activation protein alpha (FAP) in mammalian cells
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 239817 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $89 | |
Backbone
-
Vector backbonepHLsec
- Backbone size w/o insert (bp) 4511
- Total vector size (bp) 6987
-
Modifications to backboneNone
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Growth instructionsNone
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameFibroblast activation protein alpha
-
Alt nameSeprase
-
Alt nameFAP
-
Alt nameFibroblast activation protein
-
SpeciesH. sapiens (human)
-
Insert Size (bp)2229
-
MutationNo mutations
-
GenBank IDNM_004460.5 NM_004460.5
-
Entrez GeneFAP (a.k.a. DPPIV, FAPA, FAPalpha, SIMP)
- Promoter Chicken beta-actin
-
Tags
/ Fusion Proteins
- 8xHIS tag (C terminal on insert)
- TwinStrep tag (C terminal on insert)
Cloning Information
- Cloning method Gateway Cloning
- 5′ sequencing primer Not known, cloned by GenScript
- 3′ sequencing primer Not known, cloned by GenScript
- (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made byThe gene was cloned into the pHLsec plasmid backbone by GenScript.
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pHLsec-FAP was a gift from Ingrid De Meester (Addgene plasmid # 239817 ; http://n2t.net/addgene:239817 ; RRID:Addgene_239817) -
For your References section:
In vitro kinetic profiling by enzymatic approaches to select FAPIs with a long residence time. Verhulst E, Brzeminski P, de Groot A, Wals JW, Michiels R, Fabisiak A, Thys J, Grintsevich S, Van Rymenant Y, Peeters S, Lambregts S, Sim Y, Verstraete R, Van Wielendaele P, Berg M, Elvas F, Van Ostade X, Rosch F, Lambeir AM, De Winter H, Van Der Veken P, De Meester I. Eur J Med Chem. 2026 Feb 15;304:118494. doi: 10.1016/j.ejmech.2025.118494. Epub 2025 Dec 18. 10.1016/j.ejmech.2025.118494 PubMed 41455278